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ABSTRACT
Introduction: Smoking is the largest cause of
preventable death globally. Most smokers smoke their
first cigarette in early adolescence. We took advantage
of the widespread availability of mobile phones and
adolescents’ interest in appearance to develop a free
photoaging app which is promoted via a poster
campaign in secondary schools. This study aims to
evaluate its effectiveness regarding smoking prevalence
and students’ attitudes towards smoking.
Methods and analysis: A randomised controlled trial
is conducted with 9851 students of both genders with an
average age of 12 years in grades 6 and 7 of 126
secondary schools in Germany. At present, cigarette
smoking prevalence in our sample is 4.7%, with 4.6% of
the students currently using e-cigarettes (1.6% use
both). The prospective experimental study design
includes measurements at baseline and at 6, 12 and
24 months postintervention via a questionnaire plus a
random cotinine saliva sample at 24 months
postintervention. The study groups consist of
randomised schools receiving the Smokerface poster
campaign and control schools with comparable baseline
data (no intervention). The primary end point is the
difference of change in smoking prevalence in the
intervention group versus the difference in the control
group at 24 months follow-up. Longitudinal changes in
smoking-related attitudes, the number of new smokers
and quitters and the change in the number of never-
smokers will be compared between the two groups as
secondary outcomes.
Ethics and dissemination: Ethical approval was
obtained from the ethics committee of the University of
Gießen and the ministries of cultural affairs, both in
Germany. Results will be disseminated at conferences, in
peer-reviewed journals, on our websites and throughout
the multinational Education Against Tobacco network.
Trial registration number: NCT02544360, Pre-results.
INTRODUCTION
Smoking is a risk factor for various diseases,
leading to the highest number of avoidable
deaths in Germany and worldwide.1 Most
smokers start smoking in early adolescence2
and relatively few of those who become
regular smokers manage to quit later in
life.3 The 2016 HBSC international report
by the WHO revealed that 15% of boys and
13% of girls aged 15 years claimed to have
smoked at least once a week in Germany in
2013/2014.3 In spite of the decline in preva-
lence over recent years, strong socio-
economic and educational inequalities in
smoking exist.3–5
Strengths and limitations of this study
▪ This is the first randomised trial on app-based
tobacco prevention in the school setting.
▪ The majority of German 12-year-old pupils use
smartphones on a regular basis.
▪ The campaign is easy to implement, may be
added to existing campaigns and costs <€50 per
school.
▪ A random cotinine saliva sample is obtained for
biochemical validation.
▪ The large sample and the method of data collec-
tion provide valuable epidemiological data on
adolescent smoking in Germany.
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Many effective school-based interventions that prevent
smoking are based on external mentors and thus not
broadly available.6 This limitation is often accompanied
by high costs or organisational effort, which reduces
practical implementation in schools.7
Photoaging desktop programs in which an image is
altered to predict future appearance have been shown
to help motivate women aged 14–18 years to quit
smoking and increased the quit rate in young adults
aged 18–30 years of both genders by 21%.8 9 However,
these computer programs only reach a small audience
and are not freely available.
We took advantage of the broad availability of
smartphones and adolescents’ interest in appearance to
create the free photoaging smartphone app
‘Smokerface’. We demonstrated its implementation in a
small cross-sectional pilot study via a technique called
mirroring: The students’ altered three-dimensional self-
portraits on mobile phones or tablets were ‘mirrored’
via a projector in front of their whole grade.10 Our pilot
study showed that the app motivates German adolescents
not to smoke. However, the method of implementation
used in the pilot study cost €2 000 per school, requires
the time of health educators and longitudinal effects
were not measured. In this trial, the photoaging app is
implemented in secondary schools via a low cost (€50
per school) and widespread poster campaign.
We designed this randomised trial to answer the fol-
lowing main questions: Is this low-cost campaign effect-
ive in convincing students to use the app? Which
students are more likely to use an app revealing the
photoaging effects of smoking? How does this campaign
or the use of the app affect smoking prevalence among
the students or change their attitudes towards smoking
in accordance with the Theory of Planned Behavior?11
METHODS
Trial design
The Smokerface trial is designed as a randomised,
controlled superiority multicentred trial with two
parallel groups and a primary end point of the
difference in smoking prevalence from baseline to
follow-up compared between the two groups (ﬁgure 1).
Randomisation was externally and centrally performed
at school level with a 1:1 allocation.
A total of 126 secondary schools in 6 federal states
(details: authors’ contributions) of Germany partici-
pated in the baseline survey in the ﬁrst half of the
school year (October 2015–April 2016 depending on
the federal state) prior to randomisation. The randomi-
sation of schools based on the baseline data was com-
pleted from February through 1 May 2016. Immediately
after randomisation, the posters were hung by trained
data collectors from March through June of 2016. The
ﬁrst follow-up survey will be 6 months thereafter. At
1-year follow-up (March–June 2017) and at 2-year
follow-up (March–June 2018), the third and fourth
waves of the survey will be conducted. At 1 year
follow-up, additional posters are hung (see Intervention
section for details).
Intervention
The posters
Two standardised DIN A1 (a size of 594×841 mm) posters
advertising the app (ﬁgures 3A, B) are both hung up in
at least 50% of rooms where pupils of grades 6 and 7
attend classes. The posters include large images of the
short-term photoaging effects of smoking (1 pack a day
for 1 year) and small images of the long-term effects (1
pack a day for 15 years). The posters illustrate brittle hair
and earlier hair loss due to smoking,12 13 a higher risk of
acne and associated pimples,14 15 wrinkles, larger pores,
pale skin, yellow teeth13 16 and a higher risk of a runny
nose (common colds), which also affects outward appear-
ance negatively. The models are both male and female
and appear to be about 17 years old, so that they are per-
ceived as role models by both genders of our young target
group. The posters are in German (English translation for
publication purposes). In the corner of each poster,
pupils are asked to ﬁnd out what their faces would look
like as smokers by downloading the free Smokerface app.
A small pilot study with 91 pupils identiﬁed that 89/91
(97.8%) noticed the posters but only about 20% of
them realised that there was a free app (ﬁrst version;
ﬁgure 2A, B). Therefore, we optimised the posters to
provide a stronger call to action and added a QR code
(ﬁgure 3A, B).
Letters to students, teachers and parents
To further increase the use of the app within the
intervention group, the intervention posters will be
Figure 1 Study design.
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complemented by letters to the students, teachers and
parents (delivered along with the posters and at the
6 and 12 months follow-up) which explain the photoa-
ging effects of smoking and encourage app use.
Teachers and parents are also encouraged to use the
app with their students and all smokers are provided
quit advice (brief quit-advice and free motivational cessa-
tion app ‘Smokerstop’).
Raffle and change of posters at 12 months follow-up
To further increase adherence to the app in a way that
does not confound the effects of the original interven-
tion, a rafﬂe is implemented directly after the 1 year
follow-up. Students are informed via letter that they have
the chance to win the newest version of the iPhone
(Apple, California, USA) if they email us their
Smokerface image via the app.
Second, additional posters featuring long-term
smoking consequences are hung in the classrooms at
12-month follow-up, where the small preview face and
the large face have been swapped (ﬁgure 4A, B). This is
performed in the same manner as with the posters at
baseline. The purpose of this is to further increase the
number of app users and to counteract the diminishing
salience of the original posters to the students over time,
a process which has been described in detail with
graphic health warnings.17 However, since no selﬁe looks
the same, we expect that at least the pupils who installed
the app do not get used to the effects as fast as this is
the case with graphic health warnings.
The associated photoaging app ‘Smokerface’
The app photoages the user’s own face into an animated
future smoker’s face (after 1, 3, 6, 9, 12, 15 years of
smoking one pack a day) and contrasts the image with
the animated future face as a non-smoker18 (see online
supplementary video 1). Furthermore, the app explains
all the positive effects of not smoking on an image of a
non-smoker who appears youthful compared to the
negative effects of smoking on a prematurely aged
face.18 The app is freely available in the six most spoken
languages worldwide.
Monitoring
Posters
Our trained data collectors are required to personally
hang the posters and record this procedure in detail.
Additional posters are provided to the person respon-
sible for each school (mostly teachers) so that they can
replace posters in their schools that are vandalised or
ripped down. During the ﬁrst 12 months, each interven-
tion school will receive a bimonthly email reminder
asking how many of the posters are still hanging or have
been replaced. At the 6, 12 and 24 months follow-ups,
the percentage of posters still available and intact is
checked and noted by our trained data collectors. In
Figure 2 (A): Female version of the pretested Smokerface poster. (B): Male version of the pretested Smokerface poster.
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addition, our questionnaire for the intervention group
includes an item asking the pupils the quantity of
posters still hanging in their school (all, more than half,
less than half, none, do not know). To avoid bias
through changed classrooms in a new school year, add-
itional prospective classrooms will be targeted by the
campaign.
App stability
The stability of the Smokerface app is monitored during
the full study period via the application Crashlytics
(San Francisco, California, USA) to ensure that the app
stably operates on the majority of smartphones.
Participants
Eligibility criteria at baseline
Students from Germany attending grades 6 and 7 in all
types of regular secondary school in Germany were eli-
gible. Schools of other types or countries, or schools
that had previously participated in an Education Against
Tobacco event where the Smokerface app was presented,
were not eligible (educationtobacco.org).
Contaminated classes
All classes will be included in the ﬁnal intention-to-treat
analysis even if some control-arm classes are contami-
nated with some students who used the app. However,
app use will be assessed in both groups at the end point
and will be the basis for a secondary (sensitivity) analysis
with the methods described in the Analysis section of
this protocol.
Procedure
Data are collected via a questionnaire and a random
cotinine saliva sample. In addition to sociodemographic
data (age, gender and school type), the questionnaire
captures the smoking status of the school students con-
cerning cigarettes and multiple other tobacco products
(such as e-cigarettes and water pipes). These items are
based on three established studies19–21 and were either
used in their original form or adapted to the speciﬁc cir-
cumstances of the present study. Since no German
equivalents of the instruments were available, we used
the Conceptual Method for translation described by the
WHO/UNESCAP Project on Health and Disability
Statistics.22 Newly translated and/or modiﬁed materials
were extensively pretested and subjected to statistical
analyses (internal consistency/Cronbach’s α, exploratory
and conﬁrmatory factor analyses, which represented the
basis for item selection. Details about this procedure are
documented in the online supplementary material.
Biochemical validation
Cotinine saliva samples will be obtained from all stu-
dents who provide active written consent themselves and
parental consent at 18 months follow-up. Analysis via
Figure 3 (A): Female version of the optimised Smokerface poster. (B): Male version of the optimised Smokerface poster.
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liquid chromatography–mass spectrometry and therewith
a validation of smoking status will be performed in a
random subsample of these students. We aim at a sub-
sample size of 10% of students with active and passive
parental consent, but of at least 300 students. All
samples will be destroyed immediately after their coti-
nine level was measured and have no other purpose.
Data collection
Each data collector received training for data collection
and was required to use an adapted standardised proto-
col for data collection, an optimised version of the one
used in the Hutchinson Smoking Prevention Project,
which was discussed with and provided by the original
authors.19
Cluster-randomisation
Schools (grades 6 and 7) were externally and centrally
randomly assigned to the intervention or control group
in a ratio of 1:1 (deviating slightly due to the method of
stratiﬁcation) via computer by the Center for Clinical
Trials (KKS) in Marburg, Germany. The smoking preva-
lence within grade 7 of the school (>4.1%/≤4.1%), the
school size (>100 pupils/≤100 pupils) and the participa-
tion in ‘Smokefree’ (SF; participation vs no participa-
tion) were considered as factors for stratiﬁcation.
Smokefree
In the Rhine-Neckar region, we have to consider the
primary smoking intervention group ‘Smokefree’ (SF;
German: ‘ohnekippe’), which takes place in 32 schools
included from this area,23 as a confounder. SF is a
2 hour informational event for 7th graders taking place
in a specialised chest clinic which uses a classic fear
approach aiming to reduce smoking prevalence. Since
not all schools within our sample participate in the SF
event, stratiﬁcation is required.
Outcomes
The primary end point is deﬁned as the difference of the
change in smoking prevalence from baseline to
24-month follow-up between the two groups. The longitu-
dinal change in smoking-related attitudes in accordance
with the Theory of Planned Behavior, the number of new
smokers, the number of quitters and the change in the
number of never-smokers after 24 months will be com-
pared between the two groups as secondary outcomes.
For all end points, the number needed to treat (NNT)
will be calculated in addition. Considering the low costs
of the intervention, we predeﬁned a NNT below 100 as
clinically relevant. A smoker is deﬁned as a pupil who
claims to have used cigarettes at least 1 day in the 30 days
preceding the survey, in accordance with the established
Figure 4 (A): Female version of the optimised Smokerface poster (15-year version). (B): Male version of the optimised
Smokerface poster (15-year version).
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National Youth Tobacco Survey deﬁnition.15 Those pupils
who claim not to have smoked cigarettes in the past
30 days are deﬁned as non-smokers. All participants who
claim to have smoked more than a puff in the past
(beyond the past 30 days) are deﬁned as ex-smokers.
Statistical considerations
Sample size calculation
The sample size for comparing the primary end point
between the two groups was calculated with a two-sided
χ2 test and multiplied by the correction factor DE
(=design effect; DE=1+(m−1)×ICC; with m=cluster size,
ICC=Intraclass correlation coefﬁcient) to adjust for cor-
relation with regard to smoking prevalence within a
cluster. We calculated an ICC of 0.033, based on the
data from our recently published study on smoking
behaviour in Germany (analysis-of-variance estimator by
Zou and Donner).24 25
To detect a difference of 3% in change of smoking
prevalence from baseline to 24 months of follow-up
between the two groups with an α of 5% and a test
power of 70%, we calculated a sample size of 5645–
15 715 participants, depending on the change of
smoking prevalence of the two groups (2% vs 5% up to
9% vs 12%) and with an assumed dropout rate of 30%
to follow-up. Assuming an average cluster size of 100 par-
ticipants, ∼56–157 schools needed to be randomised.
The dropout rate of 30% is appropriate for our
24 months follow-up, as we observed <20% dropout in
our recent 6-month investigations.24 26
Data entry
Data entry is performed with the help of the current
software version of Formic Fusion by the Xerox AG
(Kloten, Switzerland) and recommended scanners.
Analysis
To examine baseline differences in pupils’ characteristics
in our experimental design, we will use χ2 tests for the
categorical variables and t-tests for continuous variables.
To test for differences in baseline and follow-up smoking
prevalence between groups, we will use a cluster-adjusted
Mantel-Haenszel χ2 test27 at a two-sided signiﬁcance
level of 5% with ‘participation in the SF event’ as a strati-
ﬁcation factor. In the main analysis, HLM (hierarchical
linear models) will be applied. HLM can handle the
nested structure of the data and will be used to test for
between-group differences in within-group changes in
smoking behaviour over time. HLM will also be used to
investigate the inﬂuence of further covariates (such as
gender, culture and social characteristics) and time-
dependent behaviour in secondary analyses. Statistical
analyses will be performed using the newest version of
SPSS Statistics (IBM Corporation, New York, USA).
The effect that missing data might have on results will
be assessed via sensitivity analysis. Dropouts (essentially
participants who withdraw consent for continued
follow-up or who are missing in the classroom during
the survey) will be included in the analysis by modern
imputation methods for missing data. Multiple imput-
ation will be used to estimate treatment effect.28
Baseline characteristics
DISCUSSION
While the use of mobile phone technology in smoking
cessation was investigated in several trials,29 this is the ﬁrst
major randomised trial on app-based prevention in the
school setting. Photoaging mobile apps in particular have
never been tested for their inﬂuence on adolescent
smoking prevalence,18 although the physical self-concept
plays the most important role for the self-esteem of ado-
lescents30 and photoaging interventions have been found
to increase the quit rates of young adult smokers.8 The
investigated intervention is freely accessible in our online
supplementary materials, easy to implement, low cost,
independent from external health educators and can be
added to existing school-based programmes.
Baseline characteristics
Our baseline survey includes the major predictors of
adolescent smoking as described in the literature.21 31
The differences between the two groups are balanced.
This large study is enrolled in six German federal
states. Our deﬁnitions for the smoking status of the
various monitored tobacco products stem from the
National Youth Tobacco Survey by the Centers for
Disease Control (Atlanta, USA).21 Data are collected by
external trained data collectors who use the same (trans-
lated) materials for training and the same data collec-
tion protocol as used in the Hutchinson Smoking
Prevention Project to ensure international comparability
and are validated at endline via a cotinine sample as
recommended in the Cochrane Analysis.7 19 All baseline
data were collected before the e-cigarette sales ban was
implemented on 1 April 2016 in Germany. This is the
ﬁrst national study to show that current e-cigarette and
cigarette smoking prevalence in grades 6 and 7 of sec-
ondary schools are the same (4.7% use cigarettes and
4.6% use e-cigarettes). Almost a third of these (1.6% of
the total sample) currently use both products at the
same time.21 The 6 months follow-up of this survey will
also reveal the effectiveness of the e-cigarette sales ban
to our very sensitive age group. The epidemiological
data presented here is therefore also valuable consider-
ing that the most cited and most recent surveys in
Germany were conducted via telephone interviews, a
method showing poor consistency with biochemical val-
idation in our age group.4 32
Quality of data collection
We monitored the quality of the data collection with the
same two items used in the Hutchinson survey: (1) Was
it explained to you that nobody else than the researchers
would see your questionnaire? (2) Did you know the day
the survey would be performed in your class?
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Table 1 Baseline characteristics
Variable Entire sample (%) (n) Intervention group (%) (n) Control group (%) (n)
Number of pupils (100) 9851 (53.2) 5238 (46.8) 4613
Number of schools (100) 126 (52.4) 66 (47.6) 60
Grammar Schools (100) 25 (16.7) 11 (23.3) 14
Gender (97.5) 9609
Female (46.8) 4612 (49.3) 2520 (46.5) 2092
Male (50.7) 4997 (50.7) 2592 (53.5) 2405
Age (98.6) 9710 (53) 5151 (47) 4559
M=12.01 (SD=0.86) M=11.98 (SD=0.84)
Number of pupils per grade (100) 9851
Missing in questionnaire (either grade 6 or 7) (1.5) 156 (0.8) 44 (2.4) 112
6 (49.7) 4892 (48.9) 2559 (50.6) 2333
7 (48.8) 4803 (50.3) 2635 (47) 2168
Current cigarette smokers
At least once in the past 30 days
(4.7 of 9756
valid answers) 463
(4.1 of 5185
valid answers) 210
(5.5 of 4571 with
valid answers) 253
Average days of use in the past 30 days M=7.91 (SD=9.78) M=8.3 (SD=9.92) M=7.58 (SD=9.68)
Average number of cigarettes smoked in the past 30 days M=42.91 (SD=105.05) M=40.6 (SD=98.6) M=44.83 (SD=110.28)
1–2 days/average cigarettes per day (acd) (2.4) 237/1.25 (1.9) 99/1.33 (3) 138/1.19
3–5 days/acd (0.7) 67/2.12 (0.6) 33/2.52 (0.7) 34/1.74
6–9 days/acd (0.5) 44/3.08 (0.4) 23/3.04 (0.5) 21/3.12
10–19 days/acd (0.4) 39/5.31 (0.4) 20/4.92 (0.4) 19/5.71
20–29 days/acd (0.3) 25/4.34 (0.2) 9/3.33 (0.4) 16/4.91
All 30 days/acd (0.5) 51/7.88 (0.5) 26/6.88 (0.5) 25/8.88
Not in the past 30 days (=non-smokers) (95.3) 9293 (95.9) 4975 (94.5) 4318
I never tried smoking, not even a puff (80.2) 7755
(n=9672 valid answers)
(80.5) 4145 (79.9) 3610
Never smoked a cigarette (never-smokers) (94.1 of 9748
valid answers) 9175
(95.2) 4931 (92.9) 4244
Ex-smokers who smoked
More than once per week (1.8) 175 (1.4) 72 (2.3) 103
Less than once per week (1.8) 177 (1.5) 77 (2.2) 100
Average age of first puff (years)
8 years or younger (11.3) 215 (12.6) 126 (9.8) 89
9–10 (20.1) 384 (19.9) 200 (20.3) 184
11–12 (57.2) 1092 (55.9) 561 (58.6) 531
13–14 (11.4) 218 (11.6) 116 (11.3) 102
Intention to smoke cigarettes (0–6)
(0=I am very sure that I will never smoke; 6=I believe that
I will start smoking within the next month)
0.51 0.49 0.53
Do you intend to quit cigarettes? (0–3)
(0=No; 3=within the next month)
0.84 0.71 0.97
Current tobacco waterpipe smokers/average days of
use in the past 30 days (ad30)
(2.3) 228/M=6.73
(SD=9.2)
(2.4) 125/M=6.93
(SD=9.34)
(2.3) 103/M=6.49
(SD=9.08)
Continued
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Table 1 Continued
Variable Entire sample (%) (n) Intervention group (%) (n) Control group (%) (n)
Current e-cigarette smokers/ad30 (4.6) 443/M=6.25 (SD=8.61) (4.6) 237/M=6.24 (SD=8.51) (4.5) 206/M=6.27 (SD=8.75)
Current cigar or cigarillo smokers/ad30 (0.6) 56/M=6.87 (SD=9.81) (0.6) 33/M=7.76 (SD=9.89) (0.5) 23/M=5.59 (SD=9.76)
Current chewing tobacco consumers/ad30 (0.2) 17/M=8.56 (SD=11.1) (0.2) 8/M=11 (SD=12.58) (0.2) 9/M=6.39 (SD=9.83)
Current Marihuana smokers/ad30 (0.8) 78/M=7.67 (SD=10.75) (0.9) 45/M=8.22 (SD=11.27) (0.7) 33/M=6.91 (SD=10.12)
Current steam stone waterpipe smokers/ad30 (1.7) 168/M=6.13 (SD=8.59) (1.9) 102/M=5.94 (SD=8.39) (1.4) 66/M=6.41 (SD=8.95)
Current use of other tobacco product/ad30 (0.7) 71/M=8.18 (SD=10.39) (0.7) 35/M=10.31 (SD=11.89) (0.8) 36/M=6.1 (SD=8.34)
Current use of two tobacco products (3.6) 351 (3.6) 187 (3.6) 164
Current use of e-cigarettes and cigarettes (1.6) 160 (1.5) 78 (1.8) 82
Current use of waterpipe with tobacco and cigarettes (1.0) 101 (1.0) 51 (1.1) 50
Ex-smokers who smoked
More than once per week (1.8) 175 (1.4) 72 (2.3) 103
Less than once per week (1.8) 177 (1.5) 77 (2.2) 100
I have at least one smoking parent (48.6) 4595 (47.7) 2386 (49.7) 2209
One of my best friends smokes (15.8) 1413 (15) 717 (16.6) 696
I have an older sibling that smokes (15.3) 1422 (13.7) 675 (17.1) 747
Migrational background
Both parents born in Germany (69.6) 6721 (66.3) 3403 (73.3) 3318
One parent born in Germany (13.1) 1263 (13.4) 689 (12.7) 574
No parent born in Germany (17.3) 1670 (20.2) 1038 (14) 632
School performance (self-reported point average) (96) 9460 (53) 5011 (47) 4449
M=2.44 (SD=0.79) M=2.45 (SD=0.8)
Educational level (1–5) (1=no completed school education; 5=completed university)
Father 3.62 3.58 3.67
Mother 3.6 3.57 3.64
‘Do you live in the same household with your parents?’
I live with no parent (5) 488 (5) 262 (4.9) 226
I live with one parent (24.5) 2408 (23.8) 1247 (25.1) 1161
I live with both parents (70.6) 6955 (71.2) 3729 (69.9) 3226
Student participation rate (69.54) 9851/14 165 (67.33) 5238/7780 (72.25) 4613/6385
‘I know that this survey is anonymous and what that means’. (88.4) 8520 (87.7) 4475 (89.2) 4045
‘I knew that the survey would be today’. (32.6) 3121 (34.9) 1770 (30) 1351
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Item (1) was asked at the end of the questionnaire to
monitor whether the data collectors had explained this
fact in detail (and the students remember it) and (2)
was asked to monitor if the students had been able to
mentally prepare for the survey, which is considered as a
bias in school-based research which we tried to avoid
based on communications with the responsible tea-
chers.19 About 88.4% of the students remembered at the
end of the questionnaire that the data collectors had
explained the conﬁdentiality and only 32.6% of students
knew the day the survey would be conducted.
Since we were obliged to obtain active consent from
the parents and the students, almost all students who
originally agreed to participate in the survey and had
obtained parental consent eventually participated
(69.54% of all students in the schools under investiga-
tion; see table 1). A small fraction of students was not
present in the classroom when the trained data collec-
tors visited them (on average about 2 participants per
class),18 26 which cannot be avoided when external data
collectors are used.
Generalisability
Since this study was conducted only in Germany, results
might not be generalisable to other cultural or national
settings. However, cosmetic products are used by adoles-
cents in the majority of countries and the WHO is
reportedly concerned about the tobacco industry
increasingly targeting young females in their advertise-
ments.1 These developments increase the international
importance of our research.
The investigated intervention is easy to implement
and can be added to existing school-based programmes.
We provide the original posters in high resolution
for offset print on our website educationtobacco.
org/smokerface-randomized-trial.
CONCLUSION
Our research has the potential to pave the way for a new
form of low-cost and broadly available school-based
tobacco prevention in the form of poster campaigns pro-
moting a free app. This protocol has been broadly dis-
cussed with experts in the ﬁeld and novel methods have
been developed in order to evaluate this new form of
app-based tobacco prevention. Our baseline analysis
shows good comparability between the groups at base-
line after randomisation and provides new insights into
the prevalence of smoking and the use of e-cigarettes
among pupils in the 6th and 7th grades in Germany.
Dissemination
Written informed consent was obtained by the data col-
lectors from both the participants themselves and their
parents. All participant information will be stored in
locked ﬁle cabinets in areas with limited access.
Participants’ study information will not be released
outside of the study without the written permission of
the participant. Results will be disseminated at national
and international conferences, in peer-reviewed jour-
nals, on our websites and throughout the multinational
Education Against Tobacco network.
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